Advertisement

Topics

#news #biotech Roche aims for MacroGenics bullseye with $370M DART deal

07:59 EST 4 Jan 2018 | Biotech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Roche aims for MacroGenics bullseye with $370M DART deal .After its $1.7 billion deal to buy out cancer biotech Ignyta in the dying days of 2017 Roche, ahead … Continue reading

Cet article #news #biotech Roche aims for MacroGenics bullseye with $370M DART deal est apparu en premier sur Biotech 365.

Original Article: #news #biotech Roche aims for MacroGenics bullseye with $370M DART deal

NEXT ARTICLE

More From BioPortfolio on "#news #biotech Roche aims for MacroGenics bullseye with $370M DART deal"

Quick Search
Advertisement
 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...